Cargando…
Transparent Exploration of Machine Learning for Biomarker Discovery from Proteomics and Omics Data
[Image: see text] Biomarkers are of central importance for assessing the health state and to guide medical interventions and their efficacy; still, they are lacking for most diseases. Mass spectrometry (MS)-based proteomics is a powerful technology for biomarker discovery but requires sophisticated...
Autores principales: | Torun, Furkan M., Virreira Winter, Sebastian, Doll, Sophia, Riese, Felix M., Vorobyev, Artem, Mueller-Reif, Johannes B., Geyer, Philipp E., Strauss, Maximilian T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903317/ https://www.ncbi.nlm.nih.gov/pubmed/36426751 http://dx.doi.org/10.1021/acs.jproteome.2c00473 |
Ejemplares similares
-
High‐resolution serum proteome trajectories in COVID‐19 reveal patient‐specific seroconversion
por: Geyer, Philipp E, et al.
Publicado: (2021) -
Urinary proteome profiling for stratifying patients with familial Parkinson’s disease
por: Virreira Winter, Sebastian, et al.
Publicado: (2021) -
Revisiting biomarker discovery by plasma proteomics
por: Geyer, Philipp E, et al.
Publicado: (2017) -
Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end‐stage cancer patient
por: Doll, Sophia, et al.
Publicado: (2018) -
The Case for Proteomics and Phospho‐Proteomics in Personalized Cancer Medicine
por: Doll, Sophia, et al.
Publicado: (2019)